GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Humana HUM · USD

Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States

S&P 500

Compare

423.22

-2.43%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

32 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 9Strong buy
  • 10Buy
  • 12Hold
  • 1Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 423.22Average target 416.78

Low
300.00
Average
416.78
Median
412.50
High
513.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$162.56bn$167.79bn$180.38bn$189.47bn$204.59bn
Revenue, highest$163.02bn$177.27bn$193.75bn$196.85bn$212.56bn
Revenue, lowest$161.80bn$159.20bn$163.28bn$181.10bn$195.55bn
Earnings per share9.1617.0030.5234.9135.53
Earnings per share, highest9.6121.2340.4736.6837.33
Earnings per share, lowest9.0411.0324.4032.9033.49
Analysts161619915

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Forecast7.2710.29-4.052.855.9810.17-2.193.44
Reported7.6110.31-3.963.246.2711.58-2.164.16
Difference+4.7%+0.2%+2.1%+13.8%+4.9%+13.9%+1.2%+21.0%

Rating changes

Latest broker notes

  • JP MorganNeutral
  • Morgan StanleyUnderweight → Equal Weight
  • TD CowenHold
  • BarclaysEqual Weight
  • UBSNeutral
  • Raymond JamesOutperform → Market Perform
  • GuggenheimBuy
  • Evercore ISI GroupIn Line → Outperform
  • Truist SecuritiesHold
  • TD CowenHold
  • Wells FargoEqual Weight → Overweight
  • RBC CapitalSector Perform

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 9.1% a year over 10 years. Return on equity 6.7%.

Model fair value

271.06

From earnings 271.06, from revenue 366.00.

Piotroski score

3 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.